Pharmacogenomic diversity in Amazonian Indigenous populations: implications for Berlin-Frankfurt-Münster acute lymphoblastic leukemia therapy.
Amazonian Indigenous populations exhibit substantial pharmacogenomic diversity in genes relevant to Berlin-Frankfurt-Münster-based therapy and these findings identify candidate variants for functional and clinical validation and reinforce the importance of including underrepresented populations in pharmacogenomic resea...